JPRN-UMIN000015433招募中未知
Safety study of methotrexate low-dose once daily administration in rheumatoid arthritis patients - Safety study of MTX once daily administration in RA patients
Department of Medical Pharmaceutics , Graduate School of Medicine and Pharmaceutical Sciences for Research, University of Toyama0 个研究点目标入组 35 人开始时间: 2014年11月1日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 35
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients were excluded from the study if any of the following criteria applied: (1) concurrent pregnancy, (2) the presence of serious complications in the heart, lung, kidney, etc., (3) perform of surgical operation for rheumatoid arthritis within a period of 6 months before administration (4) use of glucocorticoids(10.1 mg/day) within a period of one month before administration , (5)patients have received biological products, tacrolimus, mizoribin or (6) any other reason for which the investigator judged the patient to be unfit for study
研究者
相似试验
招募中
不适用
The clinical impact of methotrexate dose reduction at combination therapy with adalimumab plus methotrexate in rheumatoid arthritis; ALIBABA studyRheumatoid ArthritisJPRN-UMIN000024025Search Institute for Bone and Arthritis Disease (SINBAD), Shirahama Foundation for Health and Welfare80
已完成
不适用
Effects of Methotrexate on oral lichen planuslichen planus.Other lichen planusIRCT2013121715655N2Tehran University Of Medical Sciences15
尚未招募
3 期
omparison effect of single dose of Methotrexate and Actinomycin D in the prevention of gestational trophoblastic neoplasia in patients with high risk hydatidiform molegestational trophoblastic neoplasia.gestational trophoblastic neoplasmO01.9IRCT20130311012782N40Esfahan University of Medical Sciences90
已完成
不适用
Double and Single dose Methotrexate regimens in the treatment of ectopic pregnancymedical treatment of ectopic pregnancy.Tubal pregnancy Fallopian pregnancyIRCT201610085485N6Women's Reproductive Health Research Center, Vice chancellor for research, Tabriz University of Medi120
已完成
3 期
Phase III Randomised Study of High Dose Methotrexate and 5-Fluouracil Combined with Epirubicin (FEMTX) versus No Treatment in Stage II-III Resected Gastric CancerCancerISRCTN71625775Pharmacia Ltd & Upjohn (UK)